Nabriva Therapeutics plc
USD1.42
+0.01 (+0.71%)
CEO
Colin Broom
IPO Date
2017-06-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IE
Open
$1.45
Prev. Close
$1.41
Day Low
$1.35
Day High
$1.90
52W Low
$1.22
52W High
$8.45
Market Cap
$0.00B
Volume
0.71M
| -0.0 |
| 31 Dec 2020 | FY | 68.5% | -1382.2% | -209.7% | -118.9% | 0.23 | 3.09 | -0.0 |
| 31 Dec 2019 | FY | 99.1% | -1068.2% | -200.5% | -87.9% | 0.84 | 5.48 | -0.0 |
| 31 Dec 2018 | FY | 100.0% | -1765.8% | -167.2% | -104.0% | 0.35 | 6.11 | -0.0 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -90.6% | -77.6% | 0.00 | 7.08 | -0.0 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -71.0% | -58.9% | 0.00 | 5.71 | -0.0 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -28.9% | -26.6% | 0.00 | 12.49 | -0.0 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | 44.4% | -337.6% | -0.73 | 0.11 | -0.0 |
| 31 Dec 2013 | FY | 0.0% | 0.0% | -66.6% | 210.6% | -0.71 | 0.31 | 0.0 |
| -0.1 |
| 31 Dec 2022 | Q4 | -56.6% | -218.2% | -691.7% | -71.7% | 1.59 | 1.13 | -0.0 |
| 30 Sept 2022 | Q3 | 49.7% | -131.1% | -44.9% | -23.9% | 0.24 | 2.20 | -0.1 |
| 30 Jun 2022 | Q2 | 49.2% | -126.2% | -32.0% | -20.2% | 0.21 | 2.81 | -0.1 |
| 31 Mar 2022 | Q1 | 56.2% | -154.1% | -26.5% | -18.0% | 0.18 | 4.01 | -0.0 |
| 31 Dec 2021 | Q4 | 40.9% | -146.6% | -24.5% | -16.1% | 0.15 | 3.59 | -0.0 |
| 30 Sept 2021 | Q3 | 50.1% | -126.5% | -16.8% | -12.0% | 0.13 | 4.48 | -0.0 |
| 30 Jun 2021 | Q2 | 53.3% | -151.6% | -17.0% | -12.3% | 0.11 | 4.93 | -0.0 |
| 31 Mar 2021 | Q1 | 97.1% | -655.8% | -25.4% | -17.6% | 0.14 | 4.29 | -0.0 |